2-Deoxy-D- Glucose (2-DG), the Defence Research and Development Organisation (DRDO) has invited Expression of Interest (EoI) for transferring technology to Indian pharmaceutical industries for production.The applications are required to be submitted before 17 June through email. "The EoI submitted by industries will be scrutinised by a Technical Assessment Committee (TAC).
Only up to 15 industries will be given ToT on their capabilities, technical handholding capability of DRDO and on First Come First Served Basis," the EoI document read.
Requirements for the bidders include a drug license to manufacture Active Pharmaceutical Ingredient (API) from Drug Licensing Authorities and WHO GMP (Good Manufacturing Practices) certification, among.